Results 161 to 170 of about 3,251 (194)
American Journal of Medical Genetics Part A, Volume 197, Issue 6, June 2025.ABSTRACT Gastrointestinal (GI) symptoms are common in patients with Williams–Beuren syndrome (WBS), but their prevalence and possible causes are not yet fully known. This study assessed GI symptoms' prevalence and their possible origin by performing a predefined set of tests in adult WBS patients.
Maria Francesca Bedeschi +10 more
wiley +1 more source
American Journal of Medical Genetics Part A, Volume 197, Issue 6, June 2025.ABSTRACT Cystic kidney diseases (CyKD) are a diverse group of disorders affecting more than 1 in 1000 individuals. Over 120 genes are implicated, primarily encoding components of the primary cilium, transcription factors, and morphogens. Prognosis varies greatly by molecular diagnosis. Causal variants are not identified in 10%–60% of individuals due to
Deborah Watson +10 more
wiley +1 more source
Molecular Oncology, Volume 19, Issue S1, Page 1-895, June 2025.Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinics in Liver Disease, 2019
Portal hypertension (PH) is a clinical syndrome resulting from the combination of increased portal blood flow and increased portal resistance and characterized by an increase in the portosystemic gradient beyond the physiological value of 5 mmHg. PH is a common complication in patients with chronic liver disease, both adults and children, and its major
Di Giorgio A., D'Antiga L.
openaire +3 more sources
Portal hypertension (PH) is a clinical syndrome resulting from the combination of increased portal blood flow and increased portal resistance and characterized by an increase in the portosystemic gradient beyond the physiological value of 5 mmHg. PH is a common complication in patients with chronic liver disease, both adults and children, and its major
Di Giorgio A., D'Antiga L.
openaire +3 more sources
Current Opinion in Gastroenterology, 1997
Significant advances in the pathophysiology, diagnosis and management of the complications of portal hypertension that have occurred in the last year are reported.The specific areas reviewed are those that refer to experimental studies aimed at modifying the factors that lead to portal hypertension (increased intrahepatic vascular resistance and ...
openaire +9 more sources
Significant advances in the pathophysiology, diagnosis and management of the complications of portal hypertension that have occurred in the last year are reported.The specific areas reviewed are those that refer to experimental studies aimed at modifying the factors that lead to portal hypertension (increased intrahepatic vascular resistance and ...
openaire +9 more sources
Clinics in Liver Disease, 2001
Many advances in the management of portal hypertension and variceal hemorrhage have occurred during the last 10 years. Effective therapy for primary prevention of variceal hemorrhage is now available in the form of nonselective beta-blockers. Active bleeding should be managed with terlipressin, somatostatin or its analogues, and endoscopic therapy ...
N, Garcia, A J, Sanyal
openaire +2 more sources
Many advances in the management of portal hypertension and variceal hemorrhage have occurred during the last 10 years. Effective therapy for primary prevention of variceal hemorrhage is now available in the form of nonselective beta-blockers. Active bleeding should be managed with terlipressin, somatostatin or its analogues, and endoscopic therapy ...
N, Garcia, A J, Sanyal
openaire +2 more sources
Medical Clinics of North America, 1989
Portal hypertension is a frequent syndrome characterized by a chronic increase in portal venous pressure and by the formation of portal-systemic collaterals. Its main consequence is massive bleeding from ruptured esophageal and gastric varices. Bleeding is promoted by increased portal and variceal pressure, and is favored by dilatation of the varices ...
J, Bosch +4 more
openaire +2 more sources
Portal hypertension is a frequent syndrome characterized by a chronic increase in portal venous pressure and by the formation of portal-systemic collaterals. Its main consequence is massive bleeding from ruptured esophageal and gastric varices. Bleeding is promoted by increased portal and variceal pressure, and is favored by dilatation of the varices ...
J, Bosch +4 more
openaire +2 more sources
Portal‐hypertensive gastropathy
Journal of Gastroenterology and Hepatology, 1998ABSTRACTIn the present article we describe updated information concerning the clinical feature of portal‐hypertensive gastropathy (PHG), which is characterized by mucosal and submucosal vascular dilatation without inflammation. Although this lesion represents non‐variceal bleeding, there is a wide variation of its prevalence.
Tadashi Iwao, Atsushi Toyonaga
openaire +4 more sources
Portal Hypertensive Enteropathy
Gastrointestinal Endoscopy Clinics of North America, 2006The available data on the use of VCE in patients who have cirrhosis and portal hypertension are inadequate to reach a firm conclusion about the usefulness of this diagnostic tool in this patient population. In fact, only retrospective case series exist, in which the characteristics of the patients are heterogeneous in terms of severity of liver disease
E. Rondonotti +3 more
openaire +3 more sources
Gastrointestinal Endoscopy, 2002
The management of portal hypertension (PHT) and variceal hemorrhage focuses on (1) early detection of PHT, (2) early detection of gastroesophageal varices (GEV), (3) prediction of the risk of bleeding, and (4) monitoring the effects of endoscopic and pharmacologic treatments in reducing the risk of variceal bleeding.1 EUS with its unique combination of
Joseph J.Y. Sung +2 more
openaire +3 more sources
The management of portal hypertension (PHT) and variceal hemorrhage focuses on (1) early detection of PHT, (2) early detection of gastroesophageal varices (GEV), (3) prediction of the risk of bleeding, and (4) monitoring the effects of endoscopic and pharmacologic treatments in reducing the risk of variceal bleeding.1 EUS with its unique combination of
Joseph J.Y. Sung +2 more
openaire +3 more sources